Nonalcoholic fatty liver disease among HIV-infected persons.
about
Role of liver transplantation in human immunodeficiency virus positive patientsDrug Induced Steatohepatitis: An Uncommon Culprit of a Common DiseaseFatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIVTuberculosis and hepatic steatosis are prevalent liver pathology findings among HIV-infected patients in South AfricaAssociation of Abnormal Liver Function Parameters with HIV Serostatus and CD4 Count in Antiretroviral-Naive Rwandan Women.The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysisAntiretroviral Drugs and Risk of Chronic Alanine Aminotransferase Elevation in Human Immunodeficiency Virus (HIV)-Monoinfected Persons: The Data Collection on Adverse Events of Anti-HIV Drugs Study.Human immunodeficiency virus-infected and uninfected adults with non-genotype 3 hepatitis C virus have less hepatic steatosis than adults with neither infection.Liver test abnormalities in patients with HIV mono-infection: assessment with simple noninvasive fibrosis markersGenetic polymorphisms associated with fatty liver disease and fibrosis in HIV positive patients receiving combined antiretroviral therapy (cART).Liver disease, HIV and aging.Risk factors for fatty liver in the Multicenter AIDS Cohort Study.Noncommunicable diseases in HIV infection in low- and middle-income countries: gastrointestinal, hepatic, and nutritional aspects.Cost-effective screening for acute hepatitis C virus infection in HIV-infected men who have sex with men.Liver disease in the HIV-infected individual.Incidence of liver damage of uncertain origin in HIV patients not co-infected with HCV/HBV.Effect of tesamorelin on visceral fat and liver fat in HIV-infected patients with abdominal fat accumulation: a randomized clinical trialNonalcoholic Steatohepatitis and Hepatic Fibrosis in HIV-1-Monoinfected Adults With Elevated Aminotransferase Levels on Antiretroviral Therapy.Viral mechanisms of adipose dysfunction: lessons from HIV-1 VprHuman immunodeficiency virus infection and the liverSecondary causes of nonalcoholic fatty liver disease.Elevated alanine aminotransferase in antiretroviral-naïve HIV-infected African patients: magnitude and risk factors.Dysregulation of glucose metabolism in HIV patients: epidemiology, mechanisms, and management.Abnormal Myocardial Function Is Related to Myocardial Steatosis and Diffuse Myocardial Fibrosis in HIV-Infected AdultsHuman immunodeficiency virus and liver disease: An update.Lipolytic Rate Associated With Intramyocardial Lipid in an HIV Cohort Without Increased Lipolysis.Hepatic steatosis in human immunodeficiency virus: a prospective study in patients without viral hepatitis, diabetes, or alcohol abuse.Risk factors of chronic hepatitis in antiretroviral-treated HIV infection, without hepatitis B or C viral infectionRole of mitochondria in HIV infection and associated metabolic disorders: focus on nonalcoholic fatty liver disease and lipodystrophy syndrome.Liver steatosis in Chinese HIV-infected patients with hypertriglyceridemia: characteristics and independent risk factorsTraditional but not HIV-related factors are associated with nonalcoholic fatty liver disease in Asian patients with HIV-1 infection.BL153 partially prevents high-fat diet induced liver damage probably via inhibition of lipid accumulation, inflammation, and oxidative stress.Treatment of dyslipidemia in HIV-infected patients.The development of hepatoportal sclerosis and portal hypertension due to didanosine use in HIV.Treatment of dyslipidemia in HIV.Novel Approaches to Targeting Visceral and Hepatic Adiposities in HIV-Associated Lipodystrophy.Liver involvement in human immunodeficiency virus infection.Absence of liver steatosis in HIV-HCV co-infected patients receiving regimens containing tenofovir or abacavir.Use of Non-invasive Testing to Stage Liver Fibrosis in Patients with HIV.Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) in HIV.
P2860
Q26775931-EE324EE3-F4EF-4BF6-8AD8-B7C0DF2C068CQ26798157-7E26EEA3-5A42-47D0-93D3-C55039080AD0Q28079826-1C029DEB-228B-4E39-9672-90CFD9F03DFBQ28543376-318973D8-7A49-4E3F-B5D1-C674CC320B17Q30387567-E21DF8E8-A1B4-46E6-9CD4-8241D0550114Q30497534-BFDB1F04-FA73-40F0-919B-6BB65817D96EQ31050092-772618C3-71F9-4702-9AB5-6D27FBA3254DQ31149395-3EB0AA18-E0C7-4E52-ACA1-F4E49C24776EQ33621724-6EE1D3BF-936C-4EC9-9504-BA6E2D790E81Q33778556-45403539-DD1B-448C-9CA0-14390BBFE0D5Q33810577-39924F2B-EE29-4365-89B5-A90B5B5CF49CQ34049896-85E28640-BC9C-412A-A14E-435F688F99C1Q34157953-C5E09F2B-88BF-43A7-BDF3-B0891E77922EQ34227450-95288703-A6E3-4A1F-9E60-1D4D1B846385Q34380326-4D6EBF04-5D1E-48E1-8C97-D11987AFB6EAQ34852032-045FA710-7BCC-4C9D-82A9-5D2F450FA9B3Q35186541-3D4A6340-5ECB-4866-99B8-7AD9AE285B78Q35588143-E2A27EAB-A279-4180-BA1A-444538E13A96Q35834850-28476FE2-2A41-45B1-8B01-CECE7A6BD15FQ35875848-93E6D88E-B999-43C3-85AB-9247344C7A9FQ35929072-CA859909-A6F4-4D9C-B517-BCE04236C9FDQ36080888-77533245-65DC-4E3C-ABCD-7B71787A6B86Q36158019-734ADE84-1C3A-4781-9A85-4A966F0CC722Q36208623-B24C2938-E42B-4288-9FE3-113EADB414ECQ36378109-9783129A-E91C-4670-ABCB-D6578A56B670Q36431659-32CB9E8B-6746-4AEC-A74C-32173C94607AQ36532400-D30E656D-6AC2-4305-9501-D01BF07BE204Q37056681-5DD33DE5-2F7C-4F61-89BD-44174FA0947FQ37077573-9424FA4E-A65D-4773-8387-DB96101162C7Q37152712-5BC84065-675C-45EE-9725-B42A5547A109Q37539083-3619AB2E-F297-4E11-8243-573C9D449C54Q37719108-57CC2510-2846-443F-A509-11C07BED7A48Q37756963-0A833940-FA04-49B8-AA4B-D727FE66B5D3Q37807885-3E8C6E9E-503A-490A-A87A-FBF7C5FE8574Q38363531-1439C6CA-C146-4729-BE02-A58993622BFFQ38614025-CD642481-A052-4365-9B42-54167B24EEF5Q38852184-4B048A16-06D7-403D-BCA1-39A25247970AQ38915274-D7B4C6C1-1EEC-417F-AD0E-7D18F3398944Q38916843-95D4F011-8EB1-418F-8B61-0F97FFF27227Q39173801-C78C89BB-EEBF-4E7E-B433-BAE128CD0D0F
P2860
Nonalcoholic fatty liver disease among HIV-infected persons.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Nonalcoholic fatty liver disease among HIV-infected persons.
@en
Nonalcoholic fatty liver disease among HIV-infected persons.
@nl
type
label
Nonalcoholic fatty liver disease among HIV-infected persons.
@en
Nonalcoholic fatty liver disease among HIV-infected persons.
@nl
prefLabel
Nonalcoholic fatty liver disease among HIV-infected persons.
@en
Nonalcoholic fatty liver disease among HIV-infected persons.
@nl
P2093
P2860
P1476
Nonalcoholic fatty liver disease among HIV-infected persons.
@en
P2093
Alan Lifson
Angelica Dilay
Braden Hale
Charles Hames
Dean Asher
Gary Collins
Mary Bavaro
Nancy Crum-Cianflone
Richard Campin
Robin Parker
P2860
P304
P356
10.1097/QAI.0B013E318198A88A
P407
P577
2009-04-01T00:00:00Z